Sodium Selenite Pentahydrate.

Glutathione peroxidase carries a selenocysteine at its active site and uses glutathione as the electron donor. Selenium supply sets how much of that enzyme the body can build, and glutathione supply keeps it turning over.

This is the textbook selenoenzyme: without selenium there is no functional active site. Selenium status is what limits the expression of the enzyme.

Sodium selenite is reduced by ascorbate in the stomach to elemental selenium, which is red, insoluble and largely unabsorbed. Taking the two in the same dose lowers the selenium actually taken up, which is why organic selenium forms are preferred when vitamin C is in the same formula.

Vitamin C converts selenite to elemental selenium before absorption, so the mineral is lost from the dose. This is specific to the selenite salt rather than to selenium as such.

Vitamin E stops lipid chain reactions inside the membrane while the selenium-dependent glutathione peroxidases remove the peroxides that form. Each partly spares the other, a relationship established in classical nutrition work.

The enzymes that convert thyroid hormone between its forms carry selenocysteine, so normal thyroid hormone handling needs both iodine and selenium. Supplying one while the other is short leaves that conversion step under-resourced.

Selenium-dependent peroxidases run on glutathione, and cysteine availability is what limits glutathione synthesis. NAC supplies that cysteine, so the two act on different halves of the same reaction.

Zinc is structural in copper-zinc superoxide dismutase, which converts superoxide to hydrogen peroxide. Selenium-dependent glutathione peroxidase is one of the enzymes that removes the hydrogen peroxide produced. The two minerals therefore act in sequence rather than on the same reaction. This is standard trace-element pairing in multi-mineral formulation.

Glutathione reductase and thioredoxin reductase both require FAD, which is made from riboflavin. Thioredoxin reductase is itself a selenoenzyme, so selenium supplies its catalytic selenocysteine while riboflavin supplies its flavin cofactor. Poor riboflavin status slows the recycling of oxidised glutathione back to its reduced form. The relationship is textbook cofactor biochemistry and needs no trial.

Glutathione synthesis is limited by cysteine availability, and glutathione is what reduces selenite en route to selenoprotein assembly. Free cysteine also reacts with selenite directly to form selenotrisulfides, so a large thiol load changes the salt's chemistry before it is absorbed. Direction of effect depends on dose and timing rather than being uniformly favourable. Read it as speciation chemistry.

Dihydrolipoate carries two adjacent thiol groups and reduces selenite through the same selenotrisulfide route glutathione uses. It also supports the thioredoxin system, where a selenoenzyme does the catalysis. The chemistry is coherent; human data on the combination are not available. Regard it as mechanistic.

Thioredoxin reductase carries selenocysteine and is among the enzymes able to return ubiquinone to ubiquinol, the membrane-active reduced form. Selenium status therefore has a plausible influence on how efficiently that pool stays reduced. Selenium and coenzyme Q10 have been co-supplemented in nutrition research. The link here is enzymology rather than a measured combined outcome.

Selenium, sulfur and copper form poorly soluble complexes and compete during gut handling, which is why feed formulators watch their ratio. Whether this matters at human supplemental amounts has not been established. It is listed as a mineral-balance consideration for multi-mineral blends. The evidence base is animal nutrition, not human trials.

Molybdate and selenate mimic sulfate closely enough to move through the same anion transporters, and selenite shows partial overlap. Very high intakes of one oxyanion can shift the uptake of another. The work behind this is largely plant and animal mineral physiology. It is a consideration only at high mineral loads.

Selenomethionine follows methionine metabolism and can be stored in body protein, while selenite bypasses that entirely and is reduced straight to selenide. When methionine intake is high, more selenomethionine is diverted into protein rather than into selenoprotein synthesis; selenite is unaffected by that competition. This is the clearest practical difference between organic and inorganic selenium handling. Neither route is presented here as preferable.

Excess selenium leaves the body after methylation to methylselenol and then dimethylselenide and the trimethylselenonium ion, all of which draw on S-adenosylmethionine. Folate keeps that methyl supply turning over through the methionine cycle. The same cycle feeds transsulfuration to cysteine and therefore glutathione, which is what reduces selenite in the first place. Both directions are established biochemistry.